Raymond James & Associates Illumina, Inc. Transaction History

Raymond James & Associates

$150 Billion
Q2 2024

A detailed history of Raymond James & Associates transactions in Illumina, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 316,109 shares of ILMN stock, worth $41.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

316,109

Previous 370,049 14.58%

Holding current value

$41.1 Million

Previous $50.8 Million 35.07%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$101.05 - $133.57 $5.45 Million - $7.2 Million	-53,940 Reduced 14.58%	316,109 $33 Million
Q1 2024 Apr 22, 2024	BUY	$127.73 - $147.2 $2.15 Million - $2.48 Million	16,831 Added 4.77%	370,049 $50.8 Million
Q4 2023 Jan 16, 2024	SELL	$92.79 - $142.53 $2.6 Million - $3.99 Million	-28,015 Reduced 7.35%	353,218 $49.2 Million
Q3 2023 Oct 24, 2023	BUY	$128.91 - $192.44 $7.92 Million - $11.8 Million	61,444 Added 19.21%	381,233 $52.3 Million
Q2 2023 Jul 25, 2023	BUY	$183.43 - $232.67 $4.43 Million - $5.62 Million	24,140 Added 8.17%	319,789 $60 Million
Q1 2023 Apr 14, 2023	BUY	$193.75 - $232.55 $12.3 Million - $14.7 Million	63,299 Added 27.24%	295,649 $68.8 Million
Q4 2022 Feb 08, 2023	BUY	$187.24 - $242.74 $1.99 Million - $2.58 Million	10,620 Added 4.79%	232,350 $47 Million
Q3 2022 Oct 25, 2022	BUY	$177.23 - $227.44 $61,321 - $78,694	346 Added 0.16%	221,730 $42.3 Million
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $593,221 - $1.2 Million	3,267 Added 1.5%	221,384 $40.8 Million
Q1 2022 May 11, 2022	SELL	$303.87 - $423.8 $138,564 - $193,252	-456 Reduced 0.21%	218,117 $76.2 Million
Q4 2021 Feb 08, 2022	BUY	$347.28 - $421.83 $4.26 Million - $5.18 Million	12,280 Added 5.95%	218,573 $83.2 Million
Q3 2021 Nov 02, 2021	BUY	$405.61 - $524.84 $3.23 Million - $4.18 Million	7,973 Added 4.02%	206,293 $83.7 Million
Q2 2021 Aug 11, 2021	SELL	$372.84 - $481.5 $6.49 Million - $8.39 Million	-17,418 Reduced 8.07%	198,320 $93.8 Million
Q1 2021 May 14, 2021	BUY	$361.28 - $504.76 $2.55 Million - $3.57 Million	7,065 Added 3.39%	215,738 $82.9 Million
Q4 2020 Feb 12, 2021	BUY	$292.7 - $370.96 $13.3 Million - $16.8 Million	45,414 Added 27.82%	208,673 $77.2 Million
Q3 2020 Nov 04, 2020	BUY	$268.51 - $400.74 $686,043 - $1.02 Million	2,555 Added 1.59%	163,259 $50.5 Million
Q2 2020 Jul 28, 2020	BUY	$256.46 - $373.01 $10 Million - $14.6 Million	39,011 Added 32.06%	160,704 $59.5 Million
Q1 2020 Apr 21, 2020	SELL	$209.2 - $335.53 $213,593 - $342,576	-1,021 Reduced 0.83%	121,693 $33.2 Million
Q4 2019 Feb 12, 2020	BUY	$288.29 - $335.49 $240,145 - $279,463	833 Added 0.68%	122,714 $40.7 Million
Q3 2019 Nov 07, 2019	SELL	$266.84 - $378.23 $6.08 Million - $8.62 Million	-22,789 Reduced 15.75%	121,881 $37.1 Million
Q2 2019 Aug 06, 2019	BUY	$300.59 - $368.15 $4.67 Million - $5.72 Million	15,524 Added 12.02%	144,670 $53.3 Million
Q1 2019 May 06, 2019	BUY	$272.57 - $321.18 $10.7 Million - $12.6 Million	39,356 Added 43.83%	129,146 $40.1 Million
Q4 2018 Feb 11, 2019	BUY	$272.46 - $366.54 $3.1 Million - $4.17 Million	11,365 Added 14.49%	89,790 $26.9 Million
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $7.41 Million - $9.75 Million	26,568 Added 51.23%	78,425 $28.8 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $4.1 Million - $5.25 Million	17,967 Added 53.02%	51,857 $14.5 Million
Q1 2018 May 14, 2018	BUY	$209.54 - $253.91 $911,918 - $1.11 Million	4,352 Added 14.73%	33,890 $8.01 Million
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $458,253 - $521,247	2,266 Added 8.31%	29,538 $6.45 Million
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $112,511 - $139,696	653 Added 2.45%	27,272 $5.43 Million
Q2 2017 Aug 14, 2017	BUY	N/A	26,619	26,619 $4.62 Million

Others Institutions Holding ILMN

# of Institutions

852

Shares Held

138M

Call Options Held

1.41M

Put Options Held

1.66M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Illumina, Inc. Transaction History